The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 18, 2008
Filed:
Jan. 27, 2005
Yossi Cohen, Banstead, GB;
Alexander Diber, Rishon-LeZion, IL;
Amir Toporik, Azur, IL;
Sarah Pollock, Tel-Aviv, IL;
Zurit Levine, Herzlia, IL;
Michal Ayalon-soffer, Ramat-HaSharon, IL;
Gad S. Cojocaru, Ramat-HaSharon, IL;
Amit Novik, Beit-HaSharon, IL;
Guy Kol, Givat Shmuel, IL;
Osnat Sella-tavor, Kfar Kish, IL;
Shira Walach, Hod-HaSharon, IL;
Shirley Sameah-greenwald, Kfar-Saba, IL;
Dvir Dahary, Tel-Aviv, IL;
Ronen Shemesh, Modiln, IL;
Yossi Cohen, Banstead, GB;
Alexander Diber, Rishon-LeZion, IL;
Amir Toporik, Azur, IL;
Sarah Pollock, Tel-Aviv, IL;
Zurit Levine, Herzlia, IL;
Michal Ayalon-Soffer, Ramat-HaSharon, IL;
Gad S. Cojocaru, Ramat-HaSharon, IL;
Amit Novik, Beit-HaSharon, IL;
Guy Kol, Givat Shmuel, IL;
Osnat Sella-Tavor, Kfar Kish, IL;
Shira Walach, Hod-HaSharon, IL;
Shirley Sameah-Greenwald, Kfar-Saba, IL;
Dvir Dahary, Tel-Aviv, IL;
Ronen Shemesh, Modiln, IL;
Compugen Ltd., Tel Aviv, IL;
Abstract
Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.